These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6107087)

  • 21. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Oct; 16(4):273-301. PubMed ID: 359311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High affinity of SDZ HTF-919 related molecules for calf and human caudate 5-HT4 receptors.
    Hoyer D; Fehlmann D; Langenegger D; Kummer J; Giger R; Mattes H; Probst A; Pfannkuche HJ
    Ann N Y Acad Sci; 1998 Dec; 861():267-8. PubMed ID: 9928283
    [No Abstract]   [Full Text] [Related]  

  • 23. Heterogeneity of D2 dopamine receptors in different brain regions.
    Leonard MN; Macey CA; Strange PG
    Biochem J; 1987 Dec; 248(2):595-602. PubMed ID: 2963621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chiral resolution and binding study of 1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzotriazepine (10-methyl-10-azaaptazepine) and 2-methyl-1,3,4,14b-tetrahydro-2H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzothiadiazepine 10,10-dioxide (tiaaptazepine).
    De Martino G; La Regina G; La Torre F; Cirilli R; Mereghetti I; Cagnotto A; Artico M; Silvestri R
    Farmaco; 2005; 60(11-12):931-7. PubMed ID: 16223499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential therapeutic role of the enantiomers and metabolites of mianserin.
    Pinder RM; Van Delft AM
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):269S-276S. PubMed ID: 6824558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mianserin kinetics in depressed patients.
    Hrdina PD; Lapierre YD; McIntosh B; Oyewumi LK
    Clin Pharmacol Ther; 1983 Jun; 33(6):757-62. PubMed ID: 6851406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mianserin metabolites.
    Altamura AC; Melorio T
    Br J Clin Pharmacol; 1983 Aug; 16(2):201-3. PubMed ID: 6615696
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
    Gandolfi O; Barbaccia ML; Costa E
    J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mode of action of mianserin.
    Leonard BE
    Adv Biochem Psychopharmacol; 1982; 31():301-19. PubMed ID: 6282060
    [No Abstract]   [Full Text] [Related]  

  • 30. Mianserin hydrochloride: a new anti-depressant drug.
    Bennie EH
    Scott Med J; 1978 Apr; 23(2):173-5. PubMed ID: 347571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mianserin, an antidepressant with a unique neuropharmacological profile.
    Leonard BE
    Acta Psychiatr Belg; 1978; 78(5):770-80. PubMed ID: 35926
    [No Abstract]   [Full Text] [Related]  

  • 32. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
    Gobbi M; Parotti L; Mennini T
    Mol Pharmacol; 1996 Mar; 49(3):556-9. PubMed ID: 8643096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of mianserin.
    Shami M; Elliott HL; Kelman AW; Whiting B
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):313S-322S. PubMed ID: 6824562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific binding of radiolabelled antidepressants to brain astroglial cells.
    Whitaker PM; Warsh JJ
    Adv Biochem Psychopharmacol; 1983; 37():477-85. PubMed ID: 6637603
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of mianserin and danitracen, 5--hydroxytryptamine receptor blockers, on the 5--hydroxytryptamine disappearance induced by h22/54 in the rat brain.
    Maj J; Mogilnicka E; Klimek V
    Pol J Pharmacol Pharm; 1978; 30(2-3):413-20. PubMed ID: 673934
    [No Abstract]   [Full Text] [Related]  

  • 37. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
    Blackshear MA; Sanders-Bush E
    J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: The effects of a new anti-depressant, ORG GB94, on amine uptake mechanisms.
    Goodlet I; Sugrue MF
    Br J Pharmacol; 1974 Nov; 52(3):431P. PubMed ID: 4458853
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential modulation of 5-hydroxytryptamine1D binding sites by GTP and GTPgammaS.
    Harrington MA; Peroutka SJ
    Brain Res; 1990 Jan; 506(1):172-4. PubMed ID: 2405953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.